Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

JAGX
Jaguar Health, Inc.
stock NASDAQ

At Close
Sep 4, 2026 3:59:30 PM EDT
0.5968USD-14.055%(-0.0976)2,628,755
0.5900Bid   0.8100Ask   0.2300Spread
Pre-market
Sep 4, 2026 9:16:30 AM EDT
0.6735USD-3.010%(-0.0209)12,135
After-hours
Sep 4, 2026 4:59:30 PM EDT
0.5300USD-11.193%(-0.0668)1,285,207
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 13, 2022
11:47AM EST  Jaguar Health Outlines Expected 2022 Milestones   Benzinga
Jan 11, 2022
04:13PM EST  Jaguar Health 13G Filing From Oasis Capital Shows 9.99% Stake In Co.   Benzinga
Jan 4, 2022
08:35AM EST  Jaguar Health Launches Canalevia-CA1 For Treatment Of Chemotherapy-Induced Diarrhea In Dogs   Benzinga
Dec 22, 2021
08:34AM EST  Jaguar Health Offers Comments From FDA's Dec. 21-Press Release On Conditional Approval Of Co.'s Canalevia-CA1 For Treatment Of Chemo-Induced Diarrhea In Dogs   Benzinga
Dec 21, 2021
01:53PM EST  Jaguar Health Confirms Earlier Reports Of FDA Conditional Approval Of Canalevia-CA1   Benzinga
12:11PM EST  Jaguar Health Option Alert: Jan 21 $2.5 Calls Sweep (10) near the Ask: 1000 @ $0.3 vs 698 OI; Ref=$1.72   Benzinga
Dec 13, 2021
08:31AM EST  European Medicines Agency Grants Orphan Drug Designation For Crofelemer To Napo EU, Jaguar Health's Italian Subsidiary, For Short Bowel Syndrome   Benzinga
Dec 10, 2021
08:02AM EST  Jaguar Health Highlights Presentation Of Findings From Investigator-Initiated Phase 2 HALT-D Study Of Crofelemer For Prevention Of Chemo-Induced Diarrhea In Breast Cancer Patients At San Antonio Breast Cancer Symposium   Benzinga
07:50AM EST  The Daily Biotech Pulse: Lilly Sings Metabolic Disorder Drug Pact, Moderna Reports Positive Flu Vaccine Data, Halozyme To Buy Back Shares   Benzinga
Dec 6, 2021
08:37AM EST  Jaguar Health to Host Scientific Discussion About Cancer Therapy-Related Diarrhea In Breast Cancer And The Company's Ongoing OnTarget Pivotal Phase 3 Trial At San Antonio Breast Cancer Symposium Dec. 9   Benzinga
06:07AM EST  The Week Ahead In Biotech (Dec. 6-Dec. 11): Dar FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More   Benzinga
Nov 22, 2021
05:39PM EST  Jaguar Health S-3 Shows Registration For $75M Mixed Securities Shelf Offering   Benzinga
Nov 19, 2021
09:23AM EST  Jaguar Health Announces Topline Results Of Investigator-Initiated Phase 2 Study Of Crofelemer   Benzinga
Nov 17, 2021
12:03PM EST  Looking Into Jaguar Health's Return On Capital Employed   Benzinga
08:46AM EST  Jaguar Health: Q3 Earnings Insights   Benzinga
08:08AM EST  Jaguar Health Q3 EPS $(0.27) Misses $(0.17) Estimate, Sales $630.00K Miss $2.63M Estimate   Benzinga
03:59AM EST  Earnings Scheduled For November 17, 2021   Benzinga
Nov 16, 2021
12:11PM EST  Jaguar Health's Earnings Outlook   Benzinga
Nov 15, 2021
11:07AM EST  Earnings Scheduled For November 15, 2021   Benzinga
Nov 12, 2021
10:56AM EST  Earnings Preview: Jaguar Health   Benzinga
Nov 2, 2021
10:58AM EDT  Jaguar Health Reports Completed Filing Of New Animal Drug Application For Conditional Approval Of Canalevia-CA1 To Treat Chemo-Induced Diarrhea In Dogs   Benzinga
Nov 1, 2021
08:39AM EDT  Jaguar Health Shares See Light Volume Following Press Release Highlighting Closing Of Deal Between Its Italian Subsidiary, Napo EU And Dragon SPAC; BZ NOTE: The Italian Gov't. Cleared The Deal On Oct. 25   Benzinga
Oct 25, 2021
08:32AM EDT  Italian Government Clears Merger Plan Of Dragon SPAC S.p.A. And Jaguar Health's Italian Subsidiary Napo EU S.p.A. For Closing   Benzinga
Oct 13, 2021
01:39PM EDT  EXCLUSIVE: Jaguar Health CEO, Lisa Conte Now Interviewing On Benzinga's 'Power Hour' Show   Benzinga
01:38PM EDT  EXCLUSIVE: Jaguar Health CEO, Lisa Conte To Appear On Benzinga's 'Power Hour' Show At 12:30 p.m. EDT   Benzinga
Oct 7, 2021
09:48AM EDT  Jaguar Health Provides Updates on Crofelemer And Lechlemer Development Pipeline; Updates On Merger Of Napo E.U. S.p.A. And Dragon SPAC   Benzinga
Oct 1, 2021
11:14AM EDT  Jaguar Health Earnings Perspective: Return On Capital Employed   Benzinga
Sep 29, 2021
09:50AM EDT  From BZ's Small Cap Healthcare Conference: Jaguar Health President & CEO, Lisa Conte Begin Presenting   Benzinga
Sep 23, 2021
08:35AM EDT  Jaguar Health Receives 'Complete' Letter From FDA For Last Of Four Major Technical Sections For Company's Application For Conditional Approval Of Canalevia For Chemotherapy-Induced Diarrhea In Dogs   Benzinga
Sep 20, 2021
01:26PM EDT  UPDATE: Ladenburg Thalmann Says Jaguar Health Price Target Reflects 1-For-3 Reverse Stock Split And Higher Revenue Anticipated Through Commercialization Within Veterinary Market   Benzinga
01:14PM EDT  Ladenburg Thalmann Raises Jaguar Health Price Target To $13   Benzinga
Sep 15, 2021
08:34AM EDT  Jaguar Health Subsidiary Announces Orphan Drug Designation Application For Crofelemer Accepted For Review By EMA   Benzinga
Sep 8, 2021
05:52AM EDT  The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 5.25 A.M. EDT).   RTTNews
05:44AM EDT  Jaguar Health Shares Trading on 1:3 Reverse Stock Split   Benzinga
Sep 7, 2021
02:32PM EDT  Mid-Afternoon Market Update: Dow Falls Over 200 Points; RenovoRx Shares Spike Higher   Benzinga
12:12PM EDT  Mid-Day Market Update: Gold Drops 2%; Pliant Therapeutics Shares Jump   Benzinga
06:25AM EDT  The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 6.10 A.M. EDT).   RTTNews
Sep 3, 2021
04:16PM EDT  Jaguar Health, Inc. Announces 1-for-3 Reverse Stock Split, To Begin Trading On Split-Adjusted Basis On Sept. 8, 2021   Benzinga
Aug 23, 2021
08:40AM EDT  Jaguar Health Subsidiary Napo Pharmaceuticals Submits Late-Breaking Abstract For Consideration For Presentation At 2021 IDWeek Annual Meeting   Benzinga
Aug 13, 2021
07:43AM EDT  The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO   Benzinga
07:04AM EDT  Recap: Jaguar Health Q2 Earnings   Benzinga
06:32AM EDT  Jaguar Health Q2 EPS $(0.10) Misses $(0.03) Estimate, Product Revenue $385K   Benzinga
04:12AM EDT  Earnings Scheduled For August 13, 2021   Benzinga
Jul 14, 2021
08:37AM EDT  Jaguar Health Announces Completion Of Investigator-Initiated Phase 2 HALT-D Study Evaluating Mytesi (Crofelemer) For Prevention And Prophylaxis Of Diarrhea In Breast Cancer Patients   Benzinga
Jul 7, 2021
10:03AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2021   Benzinga
06:39AM EDT  Cantor Fitzgerald Initiates Coverage On Jaguar Health with Overweight Rating, Announces Price Target of $5   Benzinga
Jun 23, 2021
08:34AM EDT  Jaguar Health Set To Join Russell Microcap Index   Benzinga
Jun 11, 2021
04:17PM EDT  Jaguar Health Announces Adjournment Of Annual Meeting Of Stockholders Until Friday, July 9, 2021   Benzinga
Jun 1, 2021
08:33AM EDT  Jaguar Health & Dragon SPAC Announce Initial Funding Of US$10.8M Into Dragon SPAC   Benzinga
May 19, 2021
08:54AM EDT  Jaguar Health Announces Launch Of New Social Media Channel   Benzinga
May 18, 2021
08:40AM EDT  Jaguar Health Provides Updates On Canalevia; Says If Conditionally Approved, Canalevia Will Be Available By Q4   Benzinga
May 17, 2021
04:15PM EDT  Recap: Jaguar Health Q1 Earnings   Benzinga
08:22AM EDT  Jaguar Health Q1 EPS $(0.10) Misses $(0.02) Estimate, Sales $1.24M Up From $869.00K YoY   Benzinga
04:10AM EDT  Earnings Scheduled For May 17, 2021   Benzinga
May 14, 2021
08:35AM EDT  Jaguar Health Announces Adjournment of Annual Meeting of Stockholders Until Friday, June 11, 2021   Benzinga
Apr 29, 2021
09:39AM EDT  Jaguar Health Announces $10.8M Registered Direct Offering Of 7.647M Shares   Benzinga
08:12AM EDT  Jaguar Health And Napo Pharmaceuticals Announce Title of Abstract Regarding Patient Outcomes Associated With Cancer Therapy-Related Diarrhea Accepted For Poster Presentation At American Society Of Clinical Oncology 2021 Annual Meeting   Benzinga
Apr 15, 2021
08:38AM EDT  Jaguar Health Announces Upsizing Of At-the-Market Financing Program By $15.3M With Ladenburg Thalmann & Co. Inc. For Potential Future Financing Needs   Benzinga
Apr 14, 2021
08:36AM EDT  Jaguar Health And Napo Pharmaceuticals Announce Poster Presentation At ASCO Annual Meeting Jun. 4-8   Benzinga
Apr 8, 2021
08:40AM EDT  Jaguar Health Reports Increase In Purchase Price Of Co.'s Stock By Oasis Capital From $0.436/Share To $3/Share   Benzinga
Apr 6, 2021
08:45AM EDT  Jaguar Health Promotes Names Carol Lizak CFO   Benzinga
Mar 31, 2021
04:27PM EDT  Jaguar Health FY20 Sales $20.511M, Up 146% YoY   Benzinga
Mar 30, 2021
08:32AM EDT  Jaguar Health Announces Selection Of Investment Bank And Nominated Advisor Made By Lead Sponsor Of Planned Dragon SPAC   Benzinga
Mar 15, 2021
08:37AM EDT  Jaguar Health Announces Incorporation Of Napo EU Subsidiary In Italy; Napo EU Is Exclusive Target Of Planned Dragon SPAC   Benzinga
Mar 9, 2021
09:18AM EST  Jaguar Health Say Signs Definitive Agreement For $5M Non-Dilutive Financing Transaction Involving Sale Of Royalty Rights Related To Future Potential Crofelemer COVID-Related Indication Revenue Stream; Says No Royalty Payment Due For 36 Months   Benzinga
Mar 8, 2021
12:09PM EST  Why Are Jaguar Health Shares Surging Today?   Benzinga
Mar 5, 2021
08:34AM EST  Jaguar Health Says Enters Binding Term Sheet For $5M Non-Dilutive Financing Transaction Involving Sale Of Royalty Rights Related To Future Potential Crofelemer COVID-Related Indication Revenue Stream   Benzinga
Feb 25, 2021
10:25PM EST  Monteverde & Associates PC Announces Proposed Class Action Settlement On Behalf   PR Newswire
Feb 23, 2021
08:36AM EST  Jaguar Health Highlights Launch Of Website For Napo EU   Benzinga
Feb 19, 2021
04:44PM EST  Jaguar Health Announces A Commitment To Move Forward With Its Exclusive Relationship With The Planned Fragon SPAC, Which Is Pursuing Listing On AIM Italia And Plans To Target Napo EU   Benzinga
Feb 18, 2021
01:11PM EST  Jaguar Health In MoU With Dragon SPAC As Its Subsidiary Seeks Approval For Crofelemer In Europe   Benzinga
08:33AM EST  Jaguar Health Signs Memorandum Of Understanding With Lead Sponsor Of Planned Dragon SPAC Pursuing Listing On AIM Italia, Providing The Dragon SPAC With Exclusivity For A Proposed Business Combination With Napo EU   Benzinga
Feb 15, 2021
10:44AM EST  A Look Into Healthcare Sector Value Stocks   Benzinga
Jan 30, 2021
02:40PM EST  Robinhood Expands Trading Restrictions To 50 Stocks, Including GameStop, General Motors, Starbucks, Several SPACs   Benzinga
Jan 29, 2021
03:40PM EST  Robinhood Updates Limitations For Stock Trading   Benzinga
Jan 21, 2021
08:33AM EST  Jaguar Health And Sponsor of Proposed Post Pandemic Recovery Equity SPAC To Host Webcast Wednesday, January 27th At 8:30 AM Eastern Time To Provide Updates Regarding Potential Merger Of Napo EU, The Company's Anticipated Subsidiary in Italy   Benzinga
Jan 13, 2021
08:05AM EST  Jaguar Health Prices ~4.44M Share Common Stock Offering At $3.38/Share   Benzinga
08:05AM EST  Jaguar Health Reports Non-Dilutive Binding Term Sheet For $6M Sale Of Partial Rights To Possible Tropical Disease Priority Review Voucher   Benzinga
Jan 11, 2021
08:32AM EST  Jaguar Health Exploring Possibility Of Conditional Marketing Authorization For Proposed Inflammatory Diarrhea Indication For Crofelemer, Initially In 'Long-Hauler' COVID-19 Recovery Patients In Europe   Benzinga
Jan 9, 2021
01:02PM EST  The Week Ahead In Biotech (Jan 10-16): Expect Stocks To Move As J.P. Morgan Healthcare Conference Kicks Off   Benzinga
Jan 6, 2021
08:34AM EST  Jaguar Health Reports Its Wholly-Owned Subsidiary, Napo Pharma, Receives Preclinical Services From National Institute Of Allergy And Infectious Diseases For Study On Lechlemer Plant-Based Drug Candidate For Symptomatic Relief Of Diarrhea From Cholera   Benzinga
07:31AM EST  The Daily Biotech Pulse: Aerpio Reviews Strategic Options, Hologic Goes Shopping   Benzinga
Jan 5, 2021
09:56AM EST  Return On Capital Employed Overview: Jaguar Health   Benzinga
08:39AM EST  The Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data   Benzinga
Dec 28, 2020
10:16AM EST  5 Value Stocks In The Healthcare Sector   Benzinga
Dec 24, 2020
12:11PM EST  Mid-Day Market Update: SIFCO Industries Surges After Q4 Earnings; Future FinTech Shares Plunge   Benzinga
Dec 23, 2020
02:31PM EST  Mid-Afternoon Market Update: Bridgeline Digital Falls Following Q4 Earnings; Jaguar Health Shares Jump   Benzinga
12:11PM EST  Mid-Day Market Update: Crude Oil Rises 2%; Kubient Shares Plummet   Benzinga
08:33AM EST  Jaguar Health Signs Second Deal For $6M In Non-Dilutive Financing Related To Sale Of Royalty Rights To Future Mytesi, Lechlemer Sales Stream   Benzinga
Dec 4, 2020
08:38AM EST  Jaguar Health, On Dec. 2, Got Letter From Nasdaq Saying Stipulation For Company To Comply With Minimum Bid Price Requirement By Dec. 23   Benzinga
08:33AM EST  Jaguar Health And Subsidiary, Napo Pharmaceuticals, Enter Into Fifth Amendment To Accounts Receivable Purchase Agreement With Oasis Capital, LLC, Dated May 12, 2020   Benzinga
Dec 1, 2020
10:26AM EST  Return On Capital Employed Overview: Jaguar Health   Benzinga
Nov 30, 2020
10:20AM EST  A Look Into Healthcare Sector Value Stocks   Benzinga
08:48AM EST  Jaguar Health Announces Plan To Develop, Commercialize Crofelemer, Co's 'Novel Proprietary Drug, for the Indication of Inflammatory Diarrhea, Initially in 'Long-Hauler' COVID-19 Recovery Patients'   Benzinga
Nov 25, 2020
08:05AM EST  Jaguar Health And Subsidiary Napo Pharmaceuticals 'planning to study, develop and commercialize crofelemer'   Benzinga
Nov 17, 2020
08:32AM EST  The Daily Biotech Pulse: Setback For Alkermes, Boston Scientific's Recall, ALX-Zymeworks Oncology Collaboration   Benzinga
Nov 16, 2020
08:24AM EST  Jaguar Health Q3 EPS $(0.21) Misses $(0.11) Estimate, Sales $2.77M Miss $7.80M Estimate   Benzinga
04:26AM EST  Earnings Scheduled For November 16, 2020   Benzinga
Nov 4, 2020
08:21AM EST  The Daily Biotech Pulse: Alzheimer's Conference Underway, Biogen's Aducanumab Briefing Doc, Supernus Earnings   Benzinga
Nov 3, 2020
07:38AM EST  The Daily Biotech Pulse: Aurinia Pulls The Plug On Dry Eye Disease Study, Karyopharm's Positive Readout, Emergency Use Authorization For OraSure   Benzinga
Oct 29, 2020
08:42AM EDT  Jaguar Health Says Nasdaq Hearings Panel Granted Co. Extension Through December 23, 2020 To Evidence Compliance With The Minimum Bid Price Requirement Under Nasdaq Listing Rule   Benzinga
07:30AM EDT  The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal   Benzinga
Oct 27, 2020
08:25AM EDT  The Daily Biotech Pulse: Catabasis Halts Duchenne Muscular Dystrophy Study, Lilly's COVID-19 Trial Disappointment, Merck, Pfizer Earnings   Benzinga
Oct 22, 2020
10:26AM EDT  Stocks Trading Near 52-Week Lows Just After Open On Thursday, Oct. 22, 2020: PBT, HYLN, SNP, ATXI, VLDR, BP, AACQ, JAGX, GP, YGMZ, RMRM, RMTI, TMX   Benzinga
Oct 21, 2020
12:14PM EDT  Jaguar Health CEO And Lead Ethnobotanical Researcher Explain The Decades Of Research That Made It A Leader In Plant-Based Drug Treatment   Benzinga
09:37AM EDT  Stocks Trading Near 52-Week Lows In The Pre-Market Session On Wednesday, Oct. 21, 2020: JAGX, HYLN, BUR, ICPT, DCRBU, BXRX, IH, RDI, RBAC   Benzinga
07:47AM EDT  Jaguar Health CEO And Lead Ethnobotanical Researcher Explain The Decades Of Research That Made It A Leader In Plant-Based Drug Treatment   Benzinga
Oct 15, 2020
10:25AM EDT  Jaguar Health CEO Discusses Upcoming Virtual Event Highlighting Long-Term Treatment Needs Of Cancer Patients   Benzinga
Oct 13, 2020
08:40AM EDT  Jaguar Health Says Co Has Closed On First $6M Tranche; Says Subsidiary Napo Pharmaceuticals Enters Into 4th Amendment To Accounts Receivable Purchase Agreement With Oasis Capital   Benzinga
Oct 12, 2020
10:19AM EDT  Overview Of Value Stocks In The Healthcare Sector   Benzinga
Oct 7, 2020
08:34AM EDT  Jaguar Health Subsidiary Napo Pharmaceuticals Initiates Pivotal Phase 3 Clinical Trial Of Crofelemer For Prophylaxis Of Diarrhea In Adult Cancer Patients Receiving Targeted Cancer Therapy   Benzinga
Oct 6, 2020
08:32AM EDT  Jaguar Health Meets Financial Condition For Sale Of Royalty Rights For Mytesi (Crofelemer) Indications   Benzinga
Oct 1, 2020
08:35AM EDT  Jaguar Health Signs Agreement For Non-Dilutive Financing Transaction Involving Sale Of Royalty Rights Related To Future Mytesi Revenue Stream For $5M, With Possible Future Tranches In 2021, Totaling $16M   Benzinga
Sep 25, 2020
03:02PM EDT  Jaguar Health 13G Filing From Chicago Venture Partners Shows 8.28% Stake In Co.   Benzinga
Sep 21, 2020
09:56AM EDT  A Look Into Healthcare Sector Value Stocks   Benzinga
Sep 16, 2020
08:34AM EDT  Jaguar Health Establishes Scientific Strategy Team To 'Support Newly Launched Mental Health Entheogen Therapeutics Initiative'   Benzinga
Sep 10, 2020
08:34AM EDT  UPDATE: Jaguar Says Fourth Tranche Accounts Receivable Has A Gross Value Of $2,329,662.72, Representing Customer Billings Over A 24-Day Period   Benzinga
08:34AM EDT  Jaguar Health And Subsidiary, Napo Pharmaceuticals, Enter Third Amendment To The Accounts Receivable Purchase Agreement With Oasis Capital, LLC, Dated May 12, 2020   Benzinga
Sep 3, 2020
08:35AM EDT  Jaguar Health Announces Launch Of Mental Health Entheogen Therapeutics Initiative   Benzinga
Aug 31, 2020
08:41AM EDT  Overview Of Value Stocks In The Healthcare Sector   Benzinga
Aug 19, 2020
08:35AM EDT  Jaguar Health Provides Updates on Investigator-Initiated Trials Of Crofelemer   Benzinga
Aug 18, 2020
08:39AM EDT  Jaguar Health Submits Final Regulatory Filing For Approval Of Canalevia   Benzinga
Aug 13, 2020
08:05AM EDT  Jaguar Health Q2 EPS $(0.44) Misses $(0.15) Estimate, Sales $3.20M Miss $4.78M Estimate   Benzinga
04:03AM EDT  Earnings Scheduled For August 13, 2020   Benzinga
Aug 6, 2020
11:41AM EDT  Jaguar Health Earlier Announces Activation of Investigational New Drug (IND) for Crofelemer (Mytesi) for Prophylaxis and Symptomatic Relief of Cancer TherapyRelated Diarrhea   Benzinga
Aug 3, 2020
01:15PM EDT  5 Value Stocks In The Healthcare Sector   Benzinga
Jul 22, 2020
08:32AM EDT  Jaguar Health Subsidiary Receiving Preclinical Services From The National Institute Of Allergy And Infectious Diseases For New Preclinical Study Initiated July 21, 2020 For Lechlemer Plant-based Drug Candidate For Cholera   Benzinga
Jul 20, 2020
08:34AM EDT  FDA Invites Jaguar Health To Expedite Submission of Regulatory Filing For Approval For Canalevia To treat Chemotherapy-Induced Diarrhea In Dogs   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC